Get Real Time Here
| Open1.090 | Close1.040 |
| Vol / Avg.21.700K / 42.366K | Mkt Cap35.900M |
| Day Range1.020 - 1.090 | 52 Wk Range0.850 - 3.340 |
MiNK Therapeutics Stock (NASDAQ:INKT), Quotes and News Summary
MiNK Therapeutics Stock (NASDAQ: INKT) stock price, news, charts, stock research, profile.
| Open1.090 | Close1.040 |
| Vol / Avg.21.700K / 42.366K | Mkt Cap35.900M |
| Day Range1.020 - 1.090 | 52 Wk Range0.850 - 3.340 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.180 | -0.150 | 0.0300 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.200 | -0.180 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-10 | HC Wainwright & Co. | Emily Bodnar | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-05-12 | HC Wainwright & Co. | Emily Bodnar | Maintains | BuyBuy | Raises | 7.00 | 10.00 |
| 2023-04-19 | HC Wainwright & Co. | Emily Bodnar | Reiterates | Buy | Maintains | - | 7.00 |
| 2023-03-22 | Evercore ISI Group | Maneka Mirchandaney | Maintains | Outperform | Lowers | 4.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INKT | MiNK Therapeutics | -0.95% | 35.9M |
| GANX | Gain Therapeutics | 0.47% | 34.1M |
| OCX | OncoCyte | 0% | 31.4M |
| INTS | Intensity Therapeutics | 30.18% | 43.7M |
| COEP | Coeptis Therapeutics | 1.71% | 40.6M |
How do I buy MiNK Therapeutics (INKT) stock?
You can purchase shares of MiNK Therapeutics (NASDAQ: INKT) through any online brokerage.
Who are MiNK Therapeutics's (INKT) competitors?
Other companies in MiNK Therapeutics’s space includes: Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS), Coeptis Therapeutics (NASDAQ:COEP) and Bolt Biotherapeutics (NASDAQ:BOLT).
What is the target price for MiNK Therapeutics (INKT) stock?
The latest price target for MiNK Therapeutics (NASDAQ: INKT) was reported by HC Wainwright & Co. on Thursday, August 10, 2023. The analyst firm set a price target for 10.00 expecting INKT to rise to within 12 months (a possible 861.54% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for MiNK Therapeutics (INKT)?
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $1.04 last updated Today at December 2, 2023 at 12:28 AM UTC.
Does MiNK Therapeutics (INKT) pay a dividend?
There is no dividend information for MiNK Therapeutics.
When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?
MiNK Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is MiNK Therapeutics (INKT) going to split?
There is no upcoming split for MiNK Therapeutics.
What sector and industry does MiNK Therapeutics (INKT) operate in?
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.